ENXTPA:ERFLife Sciences
Eurofins Scientific Sticks To Growth Plan As Shares Trade Below Targets
Eurofins Scientific reported steady organic revenue growth in Q1 2026 despite temporary operational headwinds.
Challenging weather conditions and the rationalisation of some contracts affected parts of the business.
Management reiterated its 2026 and mid term objectives and confirmed continued investment in digitalisation and infrastructure.
Eurofins Scientific (ENXTPA:ERF) is trading at around €62.0, with the share price up 15.6% over the past year but showing a 10.5% decline over the past...